Latest News about INM
Recent news which mentions INM
From InvestorPlace
24 Stocks Moving in Thursday's Pre-Market Session
November 18, 2021
From Benzinga
InMed Pharmaceuticals Working to Address Rare Cannabinoid Opportunities
November 17, 2021
Tickers
INM
From Benzinga
InMed Pharmaceuticals Files Patent Application for Treatment of Neurodegenerative Diseases with Rare Cannabinoid
November 11, 2021
Tickers
INM
From Benzinga
InMed Pharmaceuticals Inc. Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid
November 03, 2021
Tickers
INM
From Benzinga
From Benzinga
From InvestorPlace
55 Biggest Movers From Friday
October 25, 2021
From Benzinga
35 Stocks Moving In Friday's Mid-Day Session
October 22, 2021
From Benzinga
26 Stocks Moving in Friday's Pre-Market Session
October 22, 2021
From Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
October 21, 2021
From Benzinga
From InvestorPlace
46 Biggest Movers From Yesterday
October 19, 2021
From Benzinga
34 Stocks Moving In Monday's Mid-Day Session
October 18, 2021
From Benzinga
From InvestorPlace
21 Stocks Moving in Monday's Pre-Market Session
October 18, 2021
From Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
October 14, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
4 Penny Stocks Insiders Are Buying
September 30, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Cannabinoids Company InMed Pharma Posts Smaller Net Loss For FY21
September 24, 2021
Tickers
INM
From Benzinga
Earnings Scheduled For September 24, 2021
September 24, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
The Week In Cannabis: FDA, CDC, Delta-8 THC, WADA, Canopy, Sundial, Canada, LatAm And More
September 17, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.